prurigo nodularis (picker's nodules)
Jump to navigation
Jump to search
Etiology
Clinical manifestations
- hyperpigmented papules or nodules
- overylying scale
- lesions may become excoriated * ulcerated
- lesions up to 2 cm in diameter
- patients scratch in multiple locations
- once itch improves, lesions gradually heal leaving light or dark spots often with scarring
Management
- if generalized, evaluate for internal causes of pruritus without primary cutaneous eruption
- chronic renal failure
- obstructive liver disease
- malignancies, especially Hodgkin's disease
- hyperthyroidism
- hypothyroidism
- polycythemia rubra vera
- acquired immune deficiency syndrome (AIDS)
- break the itch-scratch cycle
- potent topical glucocorticoids
- intralesional glucocorticoids
- oral antihistamines at night
- dupilumab FDA-approved
More general terms
References
- ↑ Medical Knowledge Self Assessment Program (MKSAP) 11, American College of Physicians, Philadelphia 1998
- ↑ Geriatric Review Syllabus, 7th edition Parada JT et al (eds) American Geriatrics Society, 2010
- ↑ 3.0 3.1 Kwatra S Clinical Review. Prurigo Nodularis: A Giant Leap Forward. The Dermatologist. Sept 2022 https://www.hmpgloballearningnetwork.com/site/thederm/clinical-review/prurigo-nodularis-giant-leap-forward
- ↑ Whang KA, Le TK, Khanna R et al. Health-related quality of life and economic burden of prurigo nodularis. J Am Acad Dermatol. 2022;86(3):573-580 PMID: https://www.ncbi.nlm.nih.gov/pubmed/34058278
- ↑ 5.0 5.1 5.2 5.3 Kwatra SG. Prurigo nodularis. JAMA Dermatol. 2022;158(3):336. PMID: https://www.ncbi.nlm.nih.gov/pubmed/35138345 https://jamanetwork.com/journals/jamadermatology/fullarticle/2788623